Winmill & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Winmill & Co's GILD Position: Q3 2018 in Review
Winmill & Co sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 30,500 shares — an estimated $2.16M sold.
Winmill & Co first reported a position in GILD in Q4 2015 and held it in 11 quarters. The position peaked at $2.47M in Q3 2017. 1,523 funds tracked by Wall St. Rank hold GILD as of Q3 2018.
- Winmill & Co reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
- Winmill & Co sold 30,500 Gilead Sciences shares in Q3 2018, an estimated $2.16M.
- Winmill & Co first reported a position in Gilead Sciences in Q4 2015 and held it in 11 quarters.
- Winmill & Co's Gilead Sciences position peaked at $2.47M in Q3 2017.
- 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.
Based on Winmill & Co's 13F filing for Q3 2018, filed 9 Oct 2018.